TY - JOUR
T1 - Hint2, A Mitochondrial Apoptotic Sensitizer Down-Regulated in Hepatocellular Carcinoma
AU - Martin, Juliette
AU - Magnino, Fabrice
AU - Schmidt, Karin
AU - Piguet, Anne Christine
AU - Lee, Ju Seog
AU - Semela, David
AU - St-Pierre, Marie V.
AU - Ziemiecki, Andrew
AU - Cassio, Doris
AU - Brenner, Charles
AU - Thorgeirsson, Snorri S.
AU - Dufour, Jean François
PY - 2006/7
Y1 - 2006/7
N2 - Background & Aims: Hints, histidine triad nucleotide-binding proteins, are adenosine monophosphate-lysine hydrolases of uncertain biological function. Here we report the characterization of human Hint2. Methods: Tissue distribution was determined by real-time quantitative polymerase chain reaction and immunoblotting, cellular localization by immunocytochemistry, and transfection with green fluorescent protein constructs. Enzymatic activities for protein kinase C and adenosine phosphoramidase in the presence of Hint2 were measured. HepG2 cell lines with Hint2 overexpressed or knocked down were established. Apoptosis was assessed by immunoblotting for caspases and by flow cytometry. Tumor growth was measured in SCID mice. Expression in human tumors was investigated by microarrays. Results: Hint2 was predominantly expressed in liver and pancreas. Hint2 was localized in mitochondria. Hint2 hydrolyzed adenosine monophosphate linked to an amino group (AMP-pNA; kcat:0.0223 s-1; Km:128 μmol/L). Exposed to apoptotic stress, fewer HepG2 cells overexpressing Hint2 remained viable (32.2 ± 0.6% vs 57.7 ± 4.6%), and more cells displayed changes of the mitochondrial membrane potential (87.8 ± 2.35 vs 49.7 ± 1.6%) with more cleaved caspases than control cells. The opposite was observed in HepG2 cells with knockdown expression of Hint2. Subcutaneous injection of HepG2 cells overexpressing Hint2 in SCID mice resulted in smaller tumors (0.32 ± 0.13 g vs 0.85 ± 0.35 g). Microarray analyses revealed that HINT2 messenger RNA is downregulated in hepatocellular carcinomas (-0.42 ± 0.58 log2 vs -0.11 ± 0.28 log2). Low abundance of HINT2 messenger RNA was associated with poor survival. Conclusion: Hint2 defines a novel class of mitochondrial apoptotic sensitizers down-regulated in hepatocellular carcinoma.
AB - Background & Aims: Hints, histidine triad nucleotide-binding proteins, are adenosine monophosphate-lysine hydrolases of uncertain biological function. Here we report the characterization of human Hint2. Methods: Tissue distribution was determined by real-time quantitative polymerase chain reaction and immunoblotting, cellular localization by immunocytochemistry, and transfection with green fluorescent protein constructs. Enzymatic activities for protein kinase C and adenosine phosphoramidase in the presence of Hint2 were measured. HepG2 cell lines with Hint2 overexpressed or knocked down were established. Apoptosis was assessed by immunoblotting for caspases and by flow cytometry. Tumor growth was measured in SCID mice. Expression in human tumors was investigated by microarrays. Results: Hint2 was predominantly expressed in liver and pancreas. Hint2 was localized in mitochondria. Hint2 hydrolyzed adenosine monophosphate linked to an amino group (AMP-pNA; kcat:0.0223 s-1; Km:128 μmol/L). Exposed to apoptotic stress, fewer HepG2 cells overexpressing Hint2 remained viable (32.2 ± 0.6% vs 57.7 ± 4.6%), and more cells displayed changes of the mitochondrial membrane potential (87.8 ± 2.35 vs 49.7 ± 1.6%) with more cleaved caspases than control cells. The opposite was observed in HepG2 cells with knockdown expression of Hint2. Subcutaneous injection of HepG2 cells overexpressing Hint2 in SCID mice resulted in smaller tumors (0.32 ± 0.13 g vs 0.85 ± 0.35 g). Microarray analyses revealed that HINT2 messenger RNA is downregulated in hepatocellular carcinomas (-0.42 ± 0.58 log2 vs -0.11 ± 0.28 log2). Low abundance of HINT2 messenger RNA was associated with poor survival. Conclusion: Hint2 defines a novel class of mitochondrial apoptotic sensitizers down-regulated in hepatocellular carcinoma.
UR - http://www.scopus.com/inward/record.url?scp=33744550097&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33744550097&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2006.03.024
DO - 10.1053/j.gastro.2006.03.024
M3 - Article
C2 - 16762638
AN - SCOPUS:33744550097
SN - 0016-5085
VL - 130
SP - 2179
EP - 2188
JO - Gastroenterology
JF - Gastroenterology
IS - 7
ER -